Organon & Co (OGN)
18.71
+0.19
(+1.03%)
USD |
NYSE |
Apr 24, 16:00
18.59
-0.12
(-0.64%)
Pre-Market: 20:00
Organon Total Liabilities (Quarterly): 12.13B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.13B |
| September 30, 2023 | 11.60B |
| June 30, 2023 | 11.53B |
| March 31, 2023 | 11.50B |
| December 31, 2022 | 11.85B |
| September 30, 2022 | 11.50B |
| June 30, 2022 | 11.75B |
| Date | Value |
|---|---|
| March 31, 2022 | 11.85B |
| December 31, 2021 | 12.19B |
| September 30, 2021 | 12.95B |
| June 30, 2021 | 12.84B |
| March 31, 2021 | 4.92B |
| December 31, 2020 | 4.623B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.623B
Minimum
Dec 2020
12.95B
Maximum
Sep 2021
10.86B
Average
11.75B
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Merck & Co Inc | 69.04B |
| Alnylam Pharmaceuticals Inc | 4.051B |
| Amgen Inc | 90.92B |
| Biogen Inc | 12.05B |
| Pacira BioSciences Inc | 704.26M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.06B |
| Shareholders Equity (Quarterly) | -70.00M |
| Debt to Equity Ratio | -125.14 |
| Current Ratio | 1.545 |
| Net Debt Paydown Yield | -0.33% |